Related Experiment Video
Updated: Apr 24, 2026

10:20
Single-cell Profiling of Developing and Mature Retinal Neurons
Published on: April 19, 2012
13.1K
Optimized Retinal Cell Dissociation for Downstream Analysis of Cone Photoreceptors
Alicia A Brunet1,2,3, Paula I Fuller-Carter4, Livia S Carvalho5,4,6
1Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, WA, Australia. alicia.brunet@lei.org.au.
Methods in Molecular Biology (Clifton, N.J.)
|April 22, 2026
Summary
We optimized retinal cell dissociation for better cone photoreceptor quality in molecular analyses. This method enhances cell viability for studies on retinal diseases and therapies.
Area of Science:
- Ophthalmology
- Cell Biology
- Neuroscience
Background:
- Isolating viable, homogenous retinal cells is crucial for molecular analyses like single-cell sequencing.
- Retinal cell dissociation is challenging due to tissue complexity and cell fragility.
- Cone photoreceptors are particularly vulnerable to degeneration, complicating their study.
Purpose of the Study:
- To develop an optimized protocol for retinal cell dissociation.
- To improve the quality and viability of cone photoreceptors for downstream molecular analysis.
- To provide a reliable method for studying retinal diseases and evaluating therapeutic interventions.
Main Methods:
- Papain enzymatic digestion of retinal tissue.
- Mechanical dissociation techniques to aid cell separation.
- Filtration to isolate viable cells and remove debris.
Main Results:
- The optimized protocol yields a high percentage of viable retinal cells.
- Minimal cell death and damage were observed, particularly for cone photoreceptors.
- The protocol effectively prepares cells for sensitive downstream molecular analyses.
Conclusions:
- This papain-based dissociation protocol enhances the quality of retinal cells, especially cones.
- The method is suitable for molecular analyses, including transcriptomics and single-cell sequencing.
- It supports disease modeling and the evaluation of gene replacement therapies for retinal conditions.

